Arkolith/Insider Trading/PALI/Form 4

Finley John David

CEO, CFO, DirectorPALISADE BIO, INC. (PALI) · full profile →Form 4 · filed Jul 8, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$303K
Net Open-Market Flow
-$303K
Transactions
5
3 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 7, 2026Sell(S)147K$2.07$303K218K
Jul 7, 2026Option exercise(M)133$0.70$93218K
Jul 6, 2026Option exercise(M)335K——364K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jul 7, 2026Option exercise(M)133—$00
Jul 6, 2026Option exercise(M)335K—$01.7M

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001493152-26-032559) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML

Keep exploring

Connected pages for PALISADE BIO, INC.

Build

Build on these Form 4 transactions

The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.

Form 4 insider API

Open-market buys and sells, cluster scans, company flows.

insider.transactions

13F holdings API

Owners, holdings, deltas, point-in-time portfolios.

stock.owners

MCP quickstart

Connect an agent, mint a key, make the first call.

/api/mcp